The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins
- PMID: 16874089
- DOI: 10.4161/auto.2882
The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins
Abstract
In the classical form of alpha-1-antitrypsin (AT) deficiency a point mutation renders aggregation-prone properties on a hepatic secretory protein. The mutant ATZ protein in retained in the endoplasmic reticulum (ER) of liver cells rather than secreted into the blood and body fluids where it ordinarily functions as an inhibitor of neutrophil proteases. A loss-of-function mechanism allows the neutrophil proteases to slowly destroy the connective tissue matrix of the lung, resulting in premature development of pulmonary emphysema as early as the third decade of life. A gain-of-toxic function mechanism is responsible for liver inflammation and carcinogenesis. Indeed this deficiency is the most common genetic cause of liver disease in children in the US. It also causes chronic liver inflammation and carcinoma that manifests itself later in life. However, the majority of affected homozygotes apparently escape liver disease. This last observation has led to the concept that genetic and/or environmental modifiers affect the disposal of mutant ATZ within the ER or affect the protective cellular responses activated by accumulation of ATZ in the ER and, in turn, these modifiers determine which homozygotes develop liver inflammation and carcinoma. In this article I review a series of studies published over the last six years showing that autophagy is specifically activated by ER accumulation of ATZ and that it plays a critical role in the disposal of this mutant protein. Indeed, the most recent studies suggest that there is specialization of the autophagic pathway in that it is specifically activated by, and designed for disposal of, the aggregated forms of ATZ while the proteasome is specialized for disposal of soluble forms of ATZ. Together, these studies provide further evidence for the importance of autophagy in the cellular adaptive response to aggregated proteins in general.
Similar articles
-
Autophagic disposal of the aggregation-prone protein that causes liver inflammation and carcinogenesis in alpha-1-antitrypsin deficiency.Cell Death Differ. 2009 Jan;16(1):39-45. doi: 10.1038/cdd.2008.103. Epub 2008 Jul 11. Cell Death Differ. 2009. PMID: 18617899 Review.
-
Multiple Genes Core to ERAD, Macroautophagy and Lysosomal Degradation Pathways Participate in the Proteostasis Response in α1-Antitrypsin Deficiency.Cell Mol Gastroenterol Hepatol. 2024;17(6):1007-1024. doi: 10.1016/j.jcmgh.2024.02.006. Epub 2024 Feb 7. Cell Mol Gastroenterol Hepatol. 2024. PMID: 38336172 Free PMC article.
-
An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.Science. 2010 Jul 9;329(5988):229-32. doi: 10.1126/science.1190354. Epub 2010 Jun 3. Science. 2010. PMID: 20522742
-
Mitochondrial autophagy and injury in the liver in alpha 1-antitrypsin deficiency.Am J Physiol Gastrointest Liver Physiol. 2004 May;286(5):G851-62. doi: 10.1152/ajpgi.00175.2003. Epub 2003 Dec 18. Am J Physiol Gastrointest Liver Physiol. 2004. PMID: 14684378
-
Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates.Annu Rev Med. 2011;62:333-45. doi: 10.1146/annurev-med-042409-151920. Annu Rev Med. 2011. PMID: 20707674 Review.
Cited by
-
The ubiquitin ligase Hrd1 promotes degradation of the Z variant alpha 1-antitrypsin and increases its solubility.Mol Cell Biochem. 2011 Jan;346(1-2):137-45. doi: 10.1007/s11010-010-0600-9. Epub 2010 Oct 1. Mol Cell Biochem. 2011. PMID: 20886262
-
ER Disposal Pathways in Chronic Liver Disease: Protective, Pathogenic, and Potential Therapeutic Targets.Front Mol Biosci. 2022 Jan 31;8:804097. doi: 10.3389/fmolb.2021.804097. eCollection 2021. Front Mol Biosci. 2022. PMID: 35174209 Free PMC article. Review.
-
Carbamazepine mitigates parenteral nutrition-associated liver disease in a novel ambulatory piglet model.JPEN J Parenter Enteral Nutr. 2022 Aug;46(6):1384-1392. doi: 10.1002/jpen.2330. Epub 2022 Feb 15. JPEN J Parenter Enteral Nutr. 2022. PMID: 35072265 Free PMC article.
-
MicroRNA regulation of autophagy in cardiovascular disease.Front Biosci (Landmark Ed). 2017 Jan 1;22(1):48-65. doi: 10.2741/4471. Front Biosci (Landmark Ed). 2017. PMID: 27814601 Free PMC article. Review.
-
Molecular chaperones and substrate ubiquitination control the efficiency of endoplasmic reticulum-associated degradation.Diabetes Obes Metab. 2010 Oct;12 Suppl 2(Suppl 2):32-8. doi: 10.1111/j.1463-1326.2010.01273.x. Diabetes Obes Metab. 2010. PMID: 21029298 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical